HI Neuro Summer Internship - DUE March 24; HI Parkinson's Center joins U Penn, UCSF, Mt to Investigate Potential DMT Inhibiting mRNA Translation of Neurotoxic Aggregating Proteins (TINAPs) to Slow Parkinson
HI Alzheimer’s Patients & Researchers Contributed to Study Leading to FDA Approval of Leqembi (Lecanemab). HI Med students work on NHPI, Diversity Published in Nature: Scientific Reports, 5th most cited journal in the world
Hi Memory Ctr became 30th US site to offer Aducanumab (Aduhelm) in phase 3b ENVISION trial; Rare CNS TB in HI described by JABSOM & TAMC residents & med student, HI patients & researchers part of Alzheimer's Lecanemab study which Slow Cognitive Decline
HI Research Team Explores Improved Alzheimer's Detection Monitoring w EEG as a Widely Available, Noninvasive & Cost Effective Biomarker: 2022 Pipeline Alzheimer's Candidates & What's Available in Hawaii?
Hawaii Recognized Nationally for Parkinson's Research. Come join Hawaii's Growing Winning Team! 100% Outpatient, No Calls, No Weekends, No BIG Institution Headaches, Moyamoya in Hawaii Published Annals Med Surgery
Hawaii Memory Center Rank #1 in US Vascular Alzheimer's Dementia Research, Hawaii Parkinson's Ctr to offer Novel BIIB122 leveraging Transport Vehicle Platform Technology to cross BBB to Slow Parkinson Progression
Summer Internship Applications open, HI Neuro COVID Clinic selected as 1 of 20 sites among Harvard, Mayo, Emory & Duke selected for NIH funded Neuro COVID to Study POST COVID Brain Fog, Fatigue, Headache, Pain, Dysautonomia, POTS, Neuropathy